United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

US · SEC FORM 4

AbbVie Inc.

ABBV · NYSE · CIK 0001551152 · Healthcare · Drug Manufacturers—General

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

13 Form 4 transaction lines observed in the same window
1 sales · 12 option, withholding, award, gift or other lines

Last qualifying purchase2020-03-30 · Durkin Brian L · $51.8K

WHY NO ACTIVE SIGNAL?

Purchase activityNone

Recent buyingNone

Recent salesLow

Buy signal statusInactive

Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated

Purchase sizeNot calculated

RoleNot calculated

RecencyNot calculated

ConvictionNot calculated

Why is there no score?

No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct

Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICER

○▼

WADDELL FREDERICK HDirector

○

Roberts Rebecca BDirector

○

RAPP EDWARD JDirector

○

Quaggin Susan EDirector

○

MEYER MELODY BDirector

○

● Purchase▼ Sale○ Other

Showing the six most active owners; 6 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2020-03-30 · Durkin Brian L.

Recent Form 4 activity

0Purchases

6Sales

59Other Form 4 lines

33SEC filings · 365 days

BUYING0 qualifying P line(s) · 180 days

SELLING1 sale line(s) · context only

OTHER12 exercise / withholding / award / gift / other lines

10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M: +0.4%
3M: +3.2%
6M: +25.8%
12M: —

Volatility & liquidity

Volatility: 25.5%
Beta: 0.28
Avg daily value: USD 1.3B

Valuation

Market cap: USD 464.4B
P/E: 74.2×

Fundamentals

Profit margin: 6.9%
ROE: —
Industry: Drug Manufacturers—General

Market data

Price data up to: 2026-10-04 · Price source: OpenBB/yfinance · From SEC filings: Profit margin · Fiscal year ended: 2025-12-31 · From Yahoo Finance: Market cap, P/E · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short: 16,280,646
Previous report: 19,494,556
Avg daily volume: 3,936,493
Days to cover: 4.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction date	Reporting owner	Type	Security	Shares	Avg. price	Approx. value	Source
2020-03-30	Durkin Brian L	Purchase (P)	Common Stock, $0.01 par value	750	USD 69.00	USD 51,750	SEC filing ↗
2020-03-20	Durkin Brian L	Purchase (P)	Common Stock, $0.01 par value	1,550	USD 69.00	USD 106,950	SEC filing ↗
2020-03-20	Durkin Brian L	Purchase (P)	Common Stock, $0.01 par value	1,550	USD 68.23	USD 105,750	SEC filing ↗
2020-03-20	Durkin Brian L	Purchase (P)	Common Stock, $0.01 par value	800	USD 67.50	USD 54,000	SEC filing ↗
2020-03-18	Durkin Brian L	Purchase (P)	Common Stock, $0.01 par value	2,200	USD 68.18	USD 149,996	SEC filing ↗
2020-03-18	Durkin Brian L	Purchase (P)	Common Stock, $0.01 par value	2,200	USD 68.18	USD 149,996	SEC filing ↗
2020-03-03	RAPP EDWARD J	Purchase (P)	Common Stock, $0.01 par value	2,875	USD 87.87	USD 252,626	SEC filing ↗

Form 4 evidence

65 transaction lines in the latest 365-day window; 771 in local history.

Date	Owner	Type	Security	Shares	Avg. price	Approx. value	Source
2026-08-14	Donoghoe Nicholas	Sale (S)	Common Stock, $0.01 par value	32,710	USD 250.00	USD 8,177,500	SEC filing ↗
2026-08-14	Donoghoe Nicholas	Option exercise / conversion (M)	Common Stock, $0.01 par value	32,710	USD 79.02	USD 2,584,744	SEC filing ↗
2026-05-08	WADDELL FREDERICK H	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗

Show recent Form 4 evidence (30 grouped rows)

Date	Owner	Type	Security	Shares	Avg. price	Approx. value	Source
2026-08-14	Donoghoe Nicholas	Sale (S)	Common Stock, $0.01 par value	32,710	USD 250.00	USD 8,177,500	SEC filing ↗
2026-08-14	Donoghoe Nicholas	Option exercise / conversion (M)	Common Stock, $0.01 par value	32,710	USD 79.02	USD 2,584,744	SEC filing ↗
2026-05-08	WADDELL FREDERICK H	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	Roberts Rebecca B	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	RAPP EDWARD J	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	Quaggin Susan E	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	MEYER MELODY B	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	Hart Brett J	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	FREYMAN THOMAS C	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	FALK THOMAS J	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	Davis Jennifer L.	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	BURNSIDE WILLIAM H.L.	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-05-08	AUSTIN ROXANNE S	Award / grant (A)	Common Stock, $0.01 par value	1,118	USD 0.00	USD 0	SEC filing ↗
2026-03-04	Purdue David Ryan	Sale (S)	Common Stock, $0.01 par value	5,230	USD 233.56	USD 1,221,519	SEC filing ↗
2026-03-02	Siatis Perry C	Sale (S)	Common Stock, $0.01 par value	18,668	USD 234.39	USD 4,375,549	SEC filing ↗
2026-02-27	Purdue David Ryan	Tax withholding (F)	Common Stock, $0.01 par value	2,108	USD 232.08	USD 489,225	SEC filing ↗
2026-02-27	Crum Demetris D	Tax withholding (F)	Common Stock, $0.01 par value	1,594	USD 232.08	USD 369,936	SEC filing ↗
2026-02-27	Thakkar Roopal	Tax withholding (F)	Common Stock, $0.01 par value	8,037	USD 232.08	USD 1,865,227	SEC filing ↗
2026-02-27	Stewart Jeffrey Ryan	Tax withholding (F)	Common Stock, $0.01 par value	23,812	USD 232.08	USD 5,526,289	SEC filing ↗
2026-02-27	Siatis Perry C	Tax withholding (F)	Common Stock, $0.01 par value	14,850	USD 232.08	USD 3,446,388	SEC filing ↗
2026-02-27	SALEKI-GERHARDT AZITA	Tax withholding (F)	Common Stock, $0.01 par value	16,309	USD 232.08	USD 3,784,993	SEC filing ↗
2026-02-27	Reents Scott T	Tax withholding (F)	Common Stock, $0.01 par value	21,638	USD 232.08	USD 5,021,747	SEC filing ↗
2026-02-27	Purdue David Ryan	Tax withholding (F)	Common Stock, $0.01 par value	2,692	USD 232.08	USD 624,759	SEC filing ↗
2026-02-27	Michael Robert A.	Tax withholding (F)	Common Stock, $0.01 par value	36,523	USD 232.08	USD 8,476,258	SEC filing ↗
2026-02-27	Donoghoe Nicholas	Tax withholding (F)	Common Stock, $0.01 par value	12,874	USD 232.08	USD 2,987,798	SEC filing ↗
2026-02-25	Siatis Perry C	Sale (S)	Common Stock, $0.01 par value	22,381	USD 230.00	USD 5,147,630	SEC filing ↗
2026-02-25	Siatis Perry C	Option exercise / conversion (M)	Common Stock, $0.01 par value	22,381	USD 172.62	USD 3,863,458	SEC filing ↗
2026-02-18	Thakkar Roopal	Award / grant (A)	Common Stock, $0.01 par value	18,137	USD 0.00	USD 0	SEC filing ↗
2026-02-18	Stewart Jeffrey Ryan	Award / grant (A)	Common Stock, $0.01 par value	53,749	USD 0.00	USD 0	SEC filing ↗
2026-02-18	Siatis Perry C	Award / grant (A)	Common Stock, $0.01 par value	33,518	USD 0.00	USD 0	SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date	2026-10-18
Ranking version	US-v1.2
Data quality	PASS ELIGIBLE · —
Ticker	ABBV
CIK	0001551152
Sector	Healthcare
Industry	Drug Manufacturers—General Yahoo Finance
SEC SIC	2834 Pharmaceutical Preparations
Exchange	NYSE

Data coverage

Local Form 4 history	771 transaction lines from 2020-01-02 to 2026-08-14 8 P purchase lines · 175 S sale lines · 588 other lines
SEC company submissions	Open SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.